Recent Progress of Src SH2 and SH3 Inhibitors as Anticancer Agents

E-ISSN： 1875-533x|17|12|1117-1124

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.17, Iss.12, 2010-04, pp. : 1117-1124

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Progress of Src Family Kinase Inhibitors as Anticancer Agents

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 10, 2008-09 ,pp. : 1053-1063

Bentham Science Publishers

Access to resources Recommend Favorite

Progress in the Development of Inhibitors of SH2 Domains

Current Pharmaceutical Design, Vol. 6, Iss. 1, 2000-01 ,pp. : 59-98

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in the Design and Synthesis of SH2 Inhibitors of Src, Grb2 and ZAP-70

Current Medicinal Chemistry, Vol. 7, Iss. 10, 2000-10 ,pp. : 1081-1100

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Progress of Small Molecular VEGFR Inhibitors as Anticancer Agents

Mini Reviews in Medicinal Chemistry, Vol. 11, Iss. 1, 2011-01 ,pp. : 18-31

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Progress in the Development of Histone Deacetylase Inhibitors as Anti-Cancer Agents

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 14, 2013-12 ,pp. : 1999-2013

Bentham Science Publishers

Access to resources Recommend Favorite